Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomed Elements is a specialized biotechnology company based in the Netherlands that focuses on the development and manufacture of advanced biomaterials for medical applications. The company utilizes a proprietary biopolymer processing platform to transform natural materials like collagen and hyaluronic acid into functional medical devices such as hemostats, wound dressings, and injectable gels. Their products are designed to support tissue repair and regeneration across various clinical fields, including surgery, orthopedics, and aesthetics. In addition to its own product portfolio, Biomed Elements operates as a contract development and manufacturing organization (CDMO), providing customized biomaterial solutions and manufacturing services to global healthcare partners. The company is ISO 13485 certified, ensuring high-quality standards for its diverse range of regenerative medicine products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomed Elements.